New All-in-One monitor aims to make surgery safer for colon cancer patients

NCT ID NCT07089017

Not yet recruiting Symptom relief Sponsor: Chinese PLA General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new device called Medstrom that monitors pain, sedation, and muscle relaxation all in one during laparoscopic colon cancer surgery. Thirty patients will be randomly assigned to either the Medstrom device or standard monitoring. The goal is to see if the device works as well as current methods and if it can help doctors make faster, better decisions during surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Medstrom medical device (pain, sedation, and neuromuscular monitoring system)
What this could lead to: If successful, this device could provide a simpler, faster way to monitor patients during surgery, potentially reducing anesthesia-related complications.
What could go wrong: This is a small, early feasibility study with only 30 participants, so results may not apply broadly. The device could cause skin irritation or signal errors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLON CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia colon carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PAIN MANAGEMENT

More trials for these conditions

Other studies related to the condition(s) this trial covers.